Rheumnow Podcast
Dr. Cush
0
Dr. Jack Cush reviews the latest news, journal reports, and regulatory decisions from the past week in rheumatology, providing concise updates for healthcare professionals.
Episodes
-
ACR 2026: Fibromyalgia Topic Panel 18.11.2026 31m -
ACR 2026 RheumNow RA Topic Compilation c 17.11.2026 38mLifestyle Interventions and Biological Effects in RAFirst theranostic approach to treat difficult-to-treat RABiologics after Cancer Is it SafeRA-ILD and Lung CancerDisease Activity in RA-ILD Worse Survival, Unclear Lung ProgressionInfliximab Biosimilar SwitchingAnti-CCP Antibody Testing on the Spot -
ACR 2026 RheumNow RA Topic Compilation b 17.11.2026 36mJAKi Cardiovascular Safety in Younger AdultsFour Joint Fibromyalgia WarningDifficult to Treat RAUse of JAK Inhibitors in Rheumatoid Arthritis-Interstitial Lung DiseaseGood News and Bad News for CCP+ at Risk for RACombination Therapy in Rheumatoid ArthritisSnippets & SNPs in ILD and FibrosisCAR-T in Rheumatoid Arthritis will it stayNot Seronegative Rheumatoid Arthritis-Interstitial Lung DiseaseWhat Happens to Muscle Mass and Muscle Strength in RA -
ACR 2026 RheumNow RA Topic Compilation a 17.11.2026 32mCan a smartphone identify inflammatory arthritisGLP-1 A game changer for lung healthMenopause in RA An Under Recognized BurdenJAK vs TNFi in RA Can Biomarkers Help us ChooseJAK1 TYK2i beats Tofacitinib in Active RARosnilimab in RA Why May it be Relatively SafeCan Gut Candida Trigger Rheumatoid Arthritis MaybeHead to Head JAK vs JAK in RAFibromyalgia and Depression in Rheumatoid ArthritisA New Way to Measure Disease Activity in Rheumatoid ArthritisStudy Design and Comparative Effectiveness in RAGLP-1 Drugs in Osteoarthritis and Rheumatoid Arthritis -
ACR 2026: RA Topic Panel 17.11.2026 31mWhat stood out in rheumatoid arthritis at ACR 2026? Join Drs. Jon Kay, Jack Cush and Artie Kavanaugh for RheumNow’s RA Topic Panel Recap. They discuss the research that caught their attention in Orlando and what the findings could mean for the everyday care of patients with RA. -
ACR 2026 RheumNow Lupus Topic Compilation d 16.11.2026 22mThe InVivo Wave Hype or Hope5mg kg HCQ Threshold in SLE Is it Time to ReconsiderLessons learned from ReBioLup data in Lupus Nephritis -
ACR 2026 RheumNow Lupus Topic Compilation c 16.11.2026 22mKidney Transplantation in LupusTreating joints and weight together TOGETHER PSABelimumab and Rituximab for SLE A Successful TrialSilent Drifts Non adherence and inflammation in SLEDrugs in Lupus Nephritis Save Kidney Function, Increase SurvivalThree Factors Shape Vaccine Response in Immune-Mediated Inflammatory Disease -
ACR 2026 RheumNow Lupus Topic Compilation b 16.11.2026 18mLupus Control without Steroid BurdenThe Lupus Outcomes GapBlock the Antibody Lupus, Myositis, SclerodermaProteinuria Another one bites the dust in lupus nephritisTirzepitide Add on or start together in PsADoes the Air we Breathe Shape Lupus -
ACR 2026 RheumNow Lupus Topic Compilation a 16.11.2026 19mStatins and eGFR in SLELong-term Opioid Use in Lupus Does Obesity Play a RoleTwo targets or one CAR-T in Lupus NephritisHydroxychloroquine Blood Levels and Retinopathy RiskWhen Low Cardiovascular Risk Misses Coronary PlaqueLow PREVENT Score, Real Risk Coronary Calcium and Heart Failure in LupusSGLT2 Inhibitors in Lupus NephritisLupus Remission is not one Single Thing -
ACR 2026 RheumNow ILD Topic Compilation c 16.11.2026 21mReal World of SARD ILDWhat are our goals, really, in ILDRA-ILD and Lung CancerDisease Activity in RA-ILD Worse Survival, Unclear Lung Progression -
ACR 2026 RheumNow ILD Topic Compilation b 16.11.2026 14mDoes Scl-Ab change predict pulmonary decline in systemic sclerosisUse of JAK Inhibitors in Rheumatoid Arthritis-Interstitial Lung DiseaseSnippets & SNPs in ILD and FibrosisInterstitial Pneumonia with Autoimmune Features (IPAF) -
ACR 2026 RheumNow ILD Topic Compilation a 16.11.2026 13mNew Treatments in ILDMortality and Myositis in ILDScreen-detected ILD in SclerodermaCan we do Pulmonary Testing at HomeVALORous Efforts in Dermatomyositis Interstitial Lung Disease -
ACR 2026 RheumNow CAR T Topic Compilation 16.11.2026 25mTwo targets or one CAR-T in Lupus NephritisNew Rheumatic Disease after CAR-TNew Treatments in Scleroderma Early DaysCAR T Without LymphodepletionCAR-T in Rheumatoid Arthritis will it stayPreliminary PK, PD, Clinical and Safety Data of NK019 in MyositisThe InVivo Wave Hype or Hope -
ACR 2026 RheumNow Fibromyalgia Topic Compilation c 16.11.2026 11mNociplastic Pain in axSpAMyositis Hurts -
ACR 2026 RheumNow Fibromyalgia Topic Compilation b 16.11.2026 7mUPSTAND study widespread pain responding to JAK inhibitionWho Manages Fibromyalgia -
ACR 2026 RheumNow Fibromyalgia Topic Compilation a 16.11.2026 9mNew Therapy for FibromyalgiaPain in axSpA may Reflect More than InflammationFibromyalgia and Depression in Rheumatoid ArthritisFour Joint Fibromyalgia Warning -
ACR 2026 RheumNow Obesity Topic Compilation c 16.11.2026 17mGLP-1 Drugs in Osteoarthritis and Rheumatoid ArthritisTreating joints and weight together TOGETHER PSAGLP-1 Agonists in Psoriatic ArthritisGLP-1s and Obesity in Rheumatic Disease -
ACR 2026 RheumNow Obesity Topic Compilation b 16.11.2026 12mRetatrutide for knee osteoarthritis and obesityOne dose for every body Rethinking drug exposureTirzepitide Add on or start together in PsACan GLP-1 Therapy Help PsA Beyond Losing Weight -
ACR 2026 RheumNow Obesity Topic Compilation a 16.11.2026 10mLong-term Opioid Use in Lupus Does Obesity Play a RoleGLP-1 A game changer for lung healthTRIUMPH-4 Retatrutide GLP-1 in OsteoarthritisIncidence of Obesity Overweight in PsA Four in Five -
ACR 2026 RheumNow PsA Topic Compilation c 16.11.2026 14mGLP-1 Agonists in Psoriatic ArthritisTNFi Failure in PsA to cycle or not cycleBiologics vs JAKi MACE and VTE Risk in PsA
Popular in
The podcast also appears in the podcast charts of these countries.